Santé (Montrouge, France)
-
Santé (Montrouge, France) · Apr 2010
[Community organizations and fighting STDs, HIV and AIDS in Montreal: lessons for sub-Saharan Africa].
The HIV/AIDS pandemic is one of the most important public health problems in the world. In Benin as elsewhere in Africa, the combination of some sociological and sociocultural factors with socio-economic realities have led this pandemic to progress faster in some farming regions than in urban areas. This survey was performed during a three-month internship researching community-based organizations in Montreal that care for HIV/AIDS patients. ⋯ the survey showed that even in high-income countries, the same risk behaviors, equally influenced by poverty, social exclusion andvulnerability, lead to this disease. Further, its chronic nature, related to essentially permanent antiretroviral treatments makes it harder for vulnerable groups to maintain healthy behaviours. The concentration of disease in vulnerable groups gives a false sense of security to most of the population, which does not feel concerned, ignores messages intended to raise awareness, and does not participate in voluntary screening. The organisations and actors involved, with the support of public health facilities, battle this vulnerability while providing information and resources to the target groups to help them protect themselves better. This struggle thus remains too focused on these target groups. Efforts must be made to make the discourse on AIDS legible to broader populations, for the borderlines between these target groups and the rest of the population is very fuzzy. Discussion and lessons: This analysis of the process of fighting HIV/AIDS inMontreal identified some positive experiences that can inspire concrete actions in African setting. One is the experience of the Farha Foundation, an organisation specialized in community fund-raising, which puts its collections at the disposal of other community organisations, and is independent, receiving no funding from local, provincial or federal public authorities. Transposition of this experience to Africa would require contextualisation and would need to mobilize the resources of not only the local community but also the national and international communities. The "Ruban en route" organization provides useful awareness programs for the young, visiting primary and secondary schools to debate HIV/AIDS issues with students with games, and demonstrating condom use. In the African context, given the limited educational system and the extent of school quitting, such an organisation would need to find a means to reach young apprentices and young farmers in informal structures. Action Séro Zero and Stella target male homosexuals and sex workers, respectively, and work to have their rights recognized by the community. The application of their policies would not be possible in our societies, for sociocultural reasons. Instead efforts must be directed toward making the community understand the need to encourage and tolerate recognition and aid for prostitutes, for the good of all. To a lesser degree, the experience of "Spectre de rue" with the TAPAJ project (Travail Alternatif Payé A la Journée or alternative work paid daily) is also importable, although only in urban environments where "street kids" are an important phenomenon. In some cities, where their number is increasing, this activity can be connected to an organisation working on awareness campaigns among the young. Contact with these street children should help them to become more socialized and to find the means to earn their living more legally. Finally, the usefulness of providing anti-retroviral treatment to people living with HIV is the most important lesson we learned during our Montreal stay. This very useful experience will nonetheless be very difficult to undertake in a rural African environment. Indeed, making antiretroviral cocktails available to patients might risk consuming the quasi-totality of the budget available for prevention. Work on this aspect is possible only if the local, national and international community mobilizes to provide the resources necessary. The international community is, however, starting to do so, by means of the Global Fund, to fight malaria, HIV/AIDS and tuberculosis. This survey has thus allowed us to learn some useful means of combatting AIDS in Africa.
-
Santé (Montrouge, France) · Apr 2010
[The epilepsy treatment gap in six primary care centres in Togo (2007-2009)].
Epilepsy, the most common serious neurological condition, is one of the most widespread non-transmissible diseases in the world. In developing countries, about 90% of those with epilepsy do not receive appropriate treatment; this treatment gap, very high compared with other chronic diseases, helps to explain the marginalisation and poor living conditions of these people. Reducing this treatment gap and the burden that epilepsy represents is a difficult task and the obstacles are numerous. ⋯ Maintaining this reduction in the treatment gap requires continuation of the struggle against epilepsy and permanent improvement of primary health care. The often unplanned moves of staff and the reluctance of district and regional health managers to allocate resources to the project to perpetuate the programme constitute major difficulties. It appears urgent to adopt an active policy for providing care of patients with epilepsy in Africa in order to increase their lifespan.
-
Santé (Montrouge, France) · Jul 2009
[Implementation of a continuum of care for people living with HIV/AIDS in Hanoi (Vietnam)].
Caring for people living with HIV/AIDS (PLWHA) encompasses various tasks, from prevention to palliative care. It involves a set of consistent and coordinated actions. This article presents the first free-of-charge management programme including antiretroviral treatment in Vietnam (as opposed to research and evaluation programmes). ⋯ To be able to succeed in implementing the continuum of care necessary for treating HIV/AIDS within its institutions, Vietnam can apply the lessons of international experience, adapted to fit local constraints and the social, cultural and political context. The shortcomings encountered in this endeavour shows how difficult it is for this country to implement such a complex set of measures at an accelerated pace. They should not, however, hide or minimize the great efforts, the vigour, and the capacity to adapt already demonstrated by local participants.
-
Santé (Montrouge, France) · Apr 2009
Comparative Study[Epidemiological, clinical and sociodemographic characteristics of human African trypanosomiasis (HAT) in and around Kinshasa, Democratic Republic of Congo].
Despite efforts to control human African trypanosomiasis (HAT) in the field, this infection remains prevalent in endemic or epidemic form in most of its traditional habitats. In the Democratic Republic of Congo (DRC), HAT has extended beyond rural areas to reach large cities such as Kinshasa. The objective of this study was to analyse the characteristics of trypanosomiasis patients (cases) in Kinshasa and to compare them to those of healthy controls. METHODS AND POPULATION OF STUDY: This case-control study allowed us to compare case patients and controls for some epidemiologic, clinical and sociodemographic characteristics. In all, 1764 people (588 case-patients and 1176 controls) were interviewed according to a structured questionnaire. Case-patients were infected with trypanosomiasis and entered the National Human African Trypanosomiasis Program (PNLTHA-DRC) from January 2004 through December 2005. Controls were matched for sex, age and residence to the corresponding case-patient, but had negative results from the Card Agglutination Trypanosomiasis Test (CATT-Test) whole-blood serologic analysis. Each patient was matched with two controls. ⋯ These results highlight several modifiable or avoidable characteristics associated with HAT. Interventions on them might make it possible to reduce the morbidity and mortality rates associated with HAT and prevent wider extension of this disease.
-
Santé (Montrouge, France) · Jul 2008
Randomized Controlled Trial Comparative Study[Intrathecal therapy with 1 500 UI of antitetanic serum and 1.5 g of intravenous metronidazole: prognosis of tetanus in hospitalized patients in Togo].
To determine the effect on clinical progression and mortality during tetanus of intrathecal therapy with 1 500 IU of heterologous antitetanus serum administered with 1.5 g of intravenous metronidazole. ⋯ Prevention through vaccination appears to be the long-term solution for the eradication of tetanus. In the meantime, we can hope for a better clinical response with intrathecal therapy of 1 500 IU of heterologous antitetanus serum and 1.5 g of intravenous metronidazole daily.